HJC-0123
Product Specifications
CAS Number
1430420-02-2
Target
Apoptosis, STAT, Others, Interleukin, TGF-beta/Smad
Related Pathways
JAK/STAT signaling, Apoptosis, Immunology/Inflammation, Others, Stem Cells
Bioactivity
Downregulate phosphorylation of STAT3, increase the expression of cleaved caspase-3, inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values. Furthermore, HJC-0123 significantly suppressed estrogen receptor (ER) -negative breast cancer MDA-MB-231 xenograft tumor growth in vivo (p.o.), indicating its great potential as an efficacious and orally bioavailable drug candidate for human cancer therapy.
Smiles
C(NC=1C=C2C(=CC1)C=CS2(=O)=O)(=O)C=3C4=C(N=C(C3)C5=CC=CC=C5)C=CC=C4
Molecular Formula
C24H16N2O3S
Molecular Weight
412.46
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP2-00362-0.025mg 0.025 mg
Rat Monoclonal GL7 (T and B Cell Activation Marker) Antibody (GL-7)
Sign In for Pricing
View Details 